<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03709615</url>
  </required_header>
  <id_info>
    <org_study_id>UHaifaCBT</org_study_id>
    <nct_id>NCT03709615</nct_id>
  </id_info>
  <brief_title>Therapeutic Processes in iCBT for SAD</brief_title>
  <official_title>Therapeutic Processes in Internet-Based CBT for Social Anxiety Disorder: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Haifa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hebrew University of Jerusalem</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Haifa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study examines therapeutic processes during internet-based cognitive-behavioral
      therapy for social anxiety disorder. Participants will be randomized to either treatment or
      wait-list conditions. Participants in the wait-list condition will receive active treatment
      following the wait-list period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Internet-based cognitive-behavioral therapy (iCBT) is an effective treatment for social
      anxiety disorder (SAD). However, little is known about the processes and mechanisms of change
      in this treatment. Compared to face to face (FTF) treatments, online interventions may
      operate through partially different mechanisms of change due to the text-based nature of the
      interaction and the reduced level of therapist involvement. The present randomized controlled
      trial will examine therapeutic processes during iCBT for SAD including the presence of sudden
      gains and their relationship to outcome, the relationship between anxiety and depressive
      symptoms along the course of treatment, changes in the therapeutic alliance and attrition
      from therapy. Moreover, we will compare iCBT for SAD with a wait-list control group and
      utilize weekly measurements of anxiety, depression, and SAD-related cognitions in both
      groups. This will facilitate comparison between temporal processes in both conditions and
      also shed light on processes occurring in wait-list conditions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 20, 2017</start_date>
  <completion_date type="Anticipated">May 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Social anxiety severity</measure>
    <time_frame>Change from Baseline LSAS at post treatment (12 weeks)</time_frame>
    <description>Post treatment Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnosis of SAD based on clinical interview</measure>
    <time_frame>Change from Baseline ADIS diagnosis at post treatment (12 weeks)</time_frame>
    <description>Diagnoses derived from the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social anxiety severity</measure>
    <time_frame>Change from Baseline LSAS at 6 months follow-up</time_frame>
    <description>Follow-up Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Social anxiety severity - additional measure</measure>
    <time_frame>Change from Baseline SPIN at post treatment (12 weeks)</time_frame>
    <description>Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social anxiety severity - additional measure</measure>
    <time_frame>Change from Baseline SPIN at 6 months follow-up</time_frame>
    <description>Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Depressive symptoms severity</measure>
    <time_frame>Change from Baseline BDI-II at post treatment (12 weeks)</time_frame>
    <description>Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.</description>
  </other_outcome>
  <other_outcome>
    <measure>Depressive symptoms severity</measure>
    <time_frame>Change from Baseline BDI-II at 6 months follow-up</time_frame>
    <description>Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Social Anxiety Disorder</condition>
  <condition>Social Phobia</condition>
  <arm_group>
    <arm_group_label>Wait list</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Wait list condition with no active treatment, length of 10 weeks, with weekly measurements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention- active treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet delivered CBT for social anxiety disorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet delivered CBT for social anxiety disorder</intervention_name>
    <description>An internet-based CBT for social anxiety based on a protocol from Andersson et al., 2006:
&quot;Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial.&quot;</description>
    <arm_group_label>Intervention- active treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meeting DSM-5 criteria for social anxiety disorder.

          -  Fluency in Hebrew

          -  Access to internet

        Exclusion Criteria:

          -  Substance use disorders

          -  Past or present psychosis

          -  High levels of suicidality

          -  Changes in pharmacological treatment 3 months or less prior to the start of the trial

          -  Participation in other psychotherapeutic treatments during the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Idan M Aderka, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Haifa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Idan M Aderka, PhD</last_name>
    <phone>972-4-8249673</phone>
    <email>iaderka@psy.haifa.ac.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jonathan G Shalom, MA</last_name>
    <phone>972-58-7002001</phone>
    <email>yonishalom@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Haifa</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Idan M Aderka, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.icbt.org.il</url>
    <description>Trial landing page (Hebrew)</description>
  </link>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>December 11, 2017</study_first_submitted>
  <study_first_submitted_qc>October 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2018</study_first_posted>
  <last_update_submitted>October 17, 2018</last_update_submitted>
  <last_update_submitted_qc>October 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Haifa</investigator_affiliation>
    <investigator_full_name>Idan Moshe Aderka</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Social anxiety disorder</keyword>
  <keyword>iCBT</keyword>
  <keyword>Therapeutic processes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

